Mark C. Mckenna - Net Worth and Insider Trading
Mark C. Mckenna Net Worth
The estimated net worth of Mark C. Mckenna is at least $12 Million dollars as of 2025-05-06. Mark C. Mckenna is the Chairman, President & CEO of Prometheus Biosciences Inc and owns about 55,144 shares of Prometheus Biosciences Inc (RXDX) stock worth over $11 Million. Mark C. Mckenna is the Director of Apogee Therapeutics Inc and owns about 20,000 shares of Apogee Therapeutics Inc (APGE) stock worth over $711,400. Mark C. Mckenna is also the President, Salix of Bausch Health Companies Inc and owns about 20,756 shares of Bausch Health Companies Inc (BHC) stock worth over $98,383. Details can be seen in Mark C. Mckenna's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark C. Mckenna has not made any transactions after 2024-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark C. Mckenna
Mark C. Mckenna Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark C. Mckenna owns 3 companies in total, including Bausch Health Companies Inc (BHC) , Prometheus Biosciences Inc (RXDX) , and Apogee Therapeutics Inc (APGE) .
Click here to see the complete history of Mark C. Mckenna’s form 4 insider trades.
Insider Ownership Summary of Mark C. Mckenna
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BHC | Bausch Health Companies Inc | 2019-08-19 | President & Salix |
| RXDX | Prometheus Biosciences Inc | 2023-03-15 | director & President and CEO |
| APGE | Apogee Therapeutics Inc | 2024-12-12 | director |
Mark C. Mckenna Latest Holdings Summary
Mark C. Mckenna currently owns a total of 3 stocks. Among these stocks, Mark C. Mckenna owns 55,144 shares of Prometheus Biosciences Inc (RXDX) as of March 15, 2023, with a value of $11 Million and a weighting of 93.16%. Mark C. Mckenna owns 20,000 shares of Apogee Therapeutics Inc (APGE) as of December 12, 2024, with a value of $711,400 and a weighting of 6.01%. Mark C. Mckenna also owns 20,756 shares of Bausch Health Companies Inc (BHC) as of August 19, 2019, with a value of $98,383 and a weighting of 0.83%.
Latest Holdings of Mark C. Mckenna
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | 2023-03-15 | 55,144 | 199.92 | 11,024,388 |
| APGE | Apogee Therapeutics Inc | 2024-12-12 | 20,000 | 35.57 | 711,400 |
| BHC | Bausch Health Companies Inc | 2019-08-19 | 20,756 | 4.74 | 98,383 |
Holding Weightings of Mark C. Mckenna
Mark C. Mckenna Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark C. Mckenna has made a total of 4 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Prometheus Biosciences Inc is the sale of 25,000 shares on March 15, 2023, which brought Mark C. Mckenna around $3 Million.
According to the SEC Form 4 filings, Mark C. Mckenna has made a total of 1 transactions in Apogee Therapeutics Inc (APGE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Apogee Therapeutics Inc is the acquisition of 20,000 shares on December 12, 2024, which cost Mark C. Mckenna around $990,800.
According to the SEC Form 4 filings, Mark C. Mckenna has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the sale of 10,773 shares on August 19, 2019, which brought Mark C. Mckenna around $235,175.
Insider Trading History of Mark C. Mckenna
- 1
Mark C. Mckenna Trading Performance
GuruFocus tracks the stock performance after each of Mark C. Mckenna's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark C. Mckenna is -13.06%. GuruFocus also compares Mark C. Mckenna's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark C. Mckenna within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark C. Mckenna's insider trading performs compared to the benchmark.
Performance of Mark C. Mckenna
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.38 |  | | | | |
| Relative Return to S&P 500(%) | -3.67 | | | | | |
Mark C. Mckenna Ownership Network
Ownership Network List of Mark C. Mckenna
Ownership Network Relation of Mark C. Mckenna
Mark C. Mckenna Owned Company Details
What does Bausch Health Companies Inc do?
Who are the key executives at Bausch Health Companies Inc?
Mark C. Mckenna is the President & Salix of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .
Bausch Health Companies Inc (BHC) Insider Trades Summary
Over the past 18 months, Mark C. Mckenna made no insider transaction in Bausch Health Companies Inc (BHC). Other recent insider transactions involving Bausch Health Companies Inc (BHC) include a net sale of 14,030 shares made by Seana Carson ,
In summary, during the past 3 months, insiders sold 0 shares of Bausch Health Companies Inc (BHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,030 shares of Bausch Health Companies Inc (BHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,030 shares.
Bausch Health Companies Inc (BHC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bausch Health Companies Inc Insider Transactions
Mark C. Mckenna Mailing Address
Above is the net worth, insider trading, and ownership report for Mark C. Mckenna. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark C. Mckenna's mailing address is: Bridgewater Nj 08807.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
